- Report
- April 2025
- 225 Pages
Global
From €4168EUR$4,500USD£3,479GBP
- Report
- April 2025
- 44 Pages
United States
- Report
- April 2025
- 130 Pages
Global
From €4493EUR$4,850USD£3,749GBP
- Report
- March 2025
- 180 Pages
China
From €1667EUR$1,800USD£1,391GBP
- Report
- November 2024
- 750 Pages
Global
From €1853EUR$2,000USD£1,546GBP
- Report
- November 2024
- 750 Pages
Global
From €1853EUR$2,000USD£1,546GBP
- Report
- October 2024
- 216 Pages
Global
From €3705EUR$4,000USD£3,092GBP
- Report
- September 2024
- 115 Pages
Global
From €4168EUR$4,500USD£3,479GBP
- Report
- July 2024
- 256 Pages
China
From €3705EUR$4,000USD£3,092GBP
- Report
- July 2023
- 223 Pages
Global
From €4168EUR$4,500USD£3,479GBP
- Report
- July 2023
- 173 Pages
Global
From €4168EUR$4,500USD£3,479GBP
- Report
- June 2023
- 22 Pages
Global
€11347EUR$12,250USD£9,469GBP
- Report
- March 2023
- 185 Pages
Global
From €2316EUR$2,500USD£1,933GBP
- Report
- November 2022
- 150 Pages
Global
From €4168EUR$4,500USD£3,479GBP
- Drug Pipelines
- October 2020
- 375 Pages
Global
From €1853EUR$2,000USD£1,546GBP
- Drug Pipelines
- September 2020
- 96 Pages
Global
From €1853EUR$2,000USD£1,546GBP
- Report
- September 2019
- 30 Pages
China
From €2038EUR$2,200USD£1,701GBP
From €3242EUR$3,500USD£2,706GBP
- Report
- November 2026
Global
From €3696EUR$3,990USD£3,084GBP
- Report
- November 2026
Global
From €3696EUR$3,990USD£3,084GBP

The Hormone Drug market is a subset of the biotechnology industry that focuses on the development and production of drugs that target hormones. These drugs are used to treat a variety of conditions, including diabetes, obesity, infertility, and menopause. Hormone drugs are typically administered through injections, patches, or pills, and are designed to mimic the body's natural hormones.
The hormone drug market is highly competitive, with many companies vying for market share. Companies in the market are typically focused on developing new drugs, as well as improving existing ones. Additionally, many companies are investing in research and development to create more effective treatments.
Notable companies in the hormone drug market include Novo Nordisk, Eli Lilly, Merck, Pfizer, and Sanofi. Show Less Read more